25 XP   0   0   10

GlaxoSmithKline PLC ADR
Buy, Hold or Sell?

Let's analyse GlaxoSmithKline PLC ADR together

PenkeI guess you are interested in GlaxoSmithKline PLC ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of GlaxoSmithKline PLC ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about GlaxoSmithKline PLC ADR

I send you an email if I find something interesting about GlaxoSmithKline PLC ADR.

Quick analysis of GlaxoSmithKline PLC ADR (30 sec.)










What can you expect buying and holding a share of GlaxoSmithKline PLC ADR? (30 sec.)

How much money do you get?

How much money do you get?
$1.14
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$3.92
Expected worth in 1 year
$1.62
How sure are you?
77.5%

+ What do you gain per year?

Total Gains per Share
$-1.17
Return On Investment
-2.7%

For what price can you sell your share?

Current Price per Share
$42.99
Expected price per share
$40.76 - $44.25
How sure are you?
50%

1. Valuation of GlaxoSmithKline PLC ADR (5 min.)




Live pricePrice per Share (EOD)

$42.99

Intrinsic Value Per Share

$-35.59 - $17.60

Total Value Per Share

$-31.66 - $21.52

2. Growth of GlaxoSmithKline PLC ADR (5 min.)




Is GlaxoSmithKline PLC ADR growing?

Current yearPrevious yearGrowGrow %
How rich?$16.1b$20.2b-$4.7b-31.1%

How much money is GlaxoSmithKline PLC ADR making?

Current yearPrevious yearGrowGrow %
Making money$1.5b$1.5b$15.1m1.0%
Net Profit Margin16.6%15.1%--

How much money comes from the company's main activities?

3. Financial Health of GlaxoSmithKline PLC ADR (5 min.)




What can you expect buying and holding a share of GlaxoSmithKline PLC ADR? (5 min.)

Welcome investor! GlaxoSmithKline PLC ADR's management wants to use your money to grow the business. In return you get a share of GlaxoSmithKline PLC ADR.

What can you expect buying and holding a share of GlaxoSmithKline PLC ADR?

First you should know what it really means to hold a share of GlaxoSmithKline PLC ADR. And how you can make/lose money.

Speculation

The Price per Share of GlaxoSmithKline PLC ADR is $42.99. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of GlaxoSmithKline PLC ADR.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in GlaxoSmithKline PLC ADR, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.92. Based on the TTM, the Book Value Change Per Share is $-0.58 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.75 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.28 per quarter.
Based on historical numbers we can estimate the returns while holding a share of GlaxoSmithKline PLC ADR.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.110.2%0.681.6%2.235.2%1.042.4%1.062.5%
Usd Book Value Change Per Share-3.82-8.9%-0.58-1.3%-1.75-4.1%0.080.2%-0.02-0.1%
Usd Dividend Per Share0.170.4%0.280.7%0.541.2%0.541.2%0.581.4%
Usd Total Gains Per Share-3.65-8.5%-0.29-0.7%-1.21-2.8%0.621.4%0.561.3%
Usd Price Per Share37.06-36.13-33.87-33.65-34.06-
Price to Earnings Ratio86.35-29.31-8.91-14.78-11.30-
Price-to-Total Gains Ratio-10.16--2.59-24.52-34.12-1.51-
Price to Book Ratio9.45-6.29-4.04-5.06-7.92-
Price-to-Total Gains Ratio-10.16--2.59-24.52-34.12-1.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share42.99
Number of shares23
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.280.54
Usd Book Value Change Per Share-0.580.08
Usd Total Gains Per Share-0.290.62
Gains per Quarter (23 shares)-6.7014.19
Gains per Year (23 shares)-26.8156.77
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
126-53-3749847
252-106-649815104
379-159-9114823161
4105-212-11819730218
5131-265-14524638275
6157-318-17229545332
7183-371-19934553389
8210-424-22639460446
9236-477-25344368503
10262-530-28049275560

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%37.03.00.092.5%92.04.00.095.8%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%14.06.00.070.0%20.020.00.050.0%53.043.00.055.2%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%93.00.03.096.9%
Total Gains per Share2.02.00.050.0%9.03.00.075.0%17.03.00.085.0%31.09.00.077.5%75.021.00.078.1%

Fundamentals of GlaxoSmithKline PLC ADR

About GlaxoSmithKline PLC ADR

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Fundamental data was last updated by Penke on 2024-03-13 23:22:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of GlaxoSmithKline PLC ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit GlaxoSmithKline PLC ADR earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare GlaxoSmithKline PLC ADR to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 4.3% means that $0.04 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of GlaxoSmithKline PLC ADR:

  • The MRQ is 4.3%. The company is making a profit. +1
  • The TTM is 16.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ4.3%TTM16.6%-12.2%
TTM16.6%YOY15.1%+1.5%
TTM16.6%5Y15.1%+1.5%
5Y15.1%10Y14.4%+0.7%
1.1.2. Return on Assets

Shows how efficient GlaxoSmithKline PLC ADR is using its assets to generate profit.

  • Above 5% is considered healthy but always compare GlaxoSmithKline PLC ADR to the Drug Manufacturers - General industry mean.
  • 0.6% Return on Assets means that GlaxoSmithKline PLC ADR generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of GlaxoSmithKline PLC ADR:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.6%TTM2.1%-1.5%
TTM2.1%YOY1.7%+0.4%
TTM2.1%5Y1.7%+0.4%
5Y1.7%10Y1.6%+0.0%
1.1.3. Return on Equity

Shows how efficient GlaxoSmithKline PLC ADR is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare GlaxoSmithKline PLC ADR to the Drug Manufacturers - General industry mean.
  • 2.6% Return on Equity means GlaxoSmithKline PLC ADR generated $0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of GlaxoSmithKline PLC ADR:

  • The MRQ is 2.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 9.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.6%TTM9.8%-7.2%
TTM9.8%YOY9.6%+0.2%
TTM9.8%5Y11.0%-1.2%
5Y11.0%10Y28.3%-17.3%

1.2. Operating Efficiency of GlaxoSmithKline PLC ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient GlaxoSmithKline PLC ADR is operating .

  • Measures how much profit GlaxoSmithKline PLC ADR makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare GlaxoSmithKline PLC ADR to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 13.1% means the company generated $0.13  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of GlaxoSmithKline PLC ADR:

  • The MRQ is 13.1%. The company is operating less efficient.
  • The TTM is 24.4%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ13.1%TTM24.4%-11.3%
TTM24.4%YOY21.2%+3.2%
TTM24.4%5Y21.4%+2.9%
5Y21.4%10Y20.5%+0.9%
1.2.2. Operating Ratio

Measures how efficient GlaxoSmithKline PLC ADR is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.87 means that the operating costs are $0.87 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of GlaxoSmithKline PLC ADR:

  • The MRQ is 0.869. The company is less efficient in keeping operating costs low.
  • The TTM is 0.758. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.869TTM0.758+0.111
TTM0.758YOY0.788-0.030
TTM0.7585Y0.794-0.036
5Y0.79410Y0.830-0.036

1.3. Liquidity of GlaxoSmithKline PLC ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if GlaxoSmithKline PLC ADR is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 0.88 means the company has $0.88 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of GlaxoSmithKline PLC ADR:

  • The MRQ is 0.885. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.915. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.885TTM0.915-0.030
TTM0.915YOY1.126-0.210
TTM0.9155Y0.910+0.005
5Y0.91010Y0.940-0.030
1.3.2. Quick Ratio

Measures if GlaxoSmithKline PLC ADR is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare GlaxoSmithKline PLC ADR to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.70 means the company can pay off $0.70 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of GlaxoSmithKline PLC ADR:

  • The MRQ is 0.704. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.800. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.704TTM0.800-0.096
TTM0.800YOY0.784+0.017
TTM0.8005Y0.604+0.197
5Y0.60410Y0.584+0.020

1.4. Solvency of GlaxoSmithKline PLC ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of GlaxoSmithKline PLC ADR assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare GlaxoSmithKline PLC ADR to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.78 means that GlaxoSmithKline PLC ADR assets are financed with 78.3% credit (debt) and the remaining percentage (100% - 78.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of GlaxoSmithKline PLC ADR:

  • The MRQ is 0.783. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.795. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.783TTM0.795-0.011
TTM0.795YOY0.795-0.001
TTM0.7955Y0.786+0.008
5Y0.78610Y0.837-0.050
1.4.2. Debt to Equity Ratio

Measures if GlaxoSmithKline PLC ADR is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare GlaxoSmithKline PLC ADR to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 346.2% means that company has $3.46 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of GlaxoSmithKline PLC ADR:

  • The MRQ is 3.462. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.716. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.462TTM3.716-0.254
TTM3.716YOY4.640-0.924
TTM3.7165Y5.425-1.709
5Y5.42510Y22.437-17.012

2. Market Valuation of GlaxoSmithKline PLC ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings GlaxoSmithKline PLC ADR generates.

  • Above 15 is considered overpriced but always compare GlaxoSmithKline PLC ADR to the Drug Manufacturers - General industry mean.
  • A PE ratio of 86.35 means the investor is paying $86.35 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of GlaxoSmithKline PLC ADR:

  • The EOD is 100.167. Based on the earnings, the company is expensive. -2
  • The MRQ is 86.350. Based on the earnings, the company is expensive. -2
  • The TTM is 29.306. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD100.167MRQ86.350+13.817
MRQ86.350TTM29.306+57.044
TTM29.306YOY8.911+20.395
TTM29.3065Y14.782+14.524
5Y14.78210Y11.298+3.484
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of GlaxoSmithKline PLC ADR:

  • The EOD is 16.023. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 13.813. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 3.893. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD16.023MRQ13.813+2.210
MRQ13.813TTM3.893+9.920
TTM3.893YOY11.420-7.527
TTM3.8935Y-12.812+16.705
5Y-12.81210Y79.717-92.529
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of GlaxoSmithKline PLC ADR is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 9.45 means the investor is paying $9.45 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of GlaxoSmithKline PLC ADR:

  • The EOD is 10.960. Based on the equity, the company is expensive. -2
  • The MRQ is 9.448. Based on the equity, the company is overpriced. -1
  • The TTM is 6.291. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD10.960MRQ9.448+1.512
MRQ9.448TTM6.291+3.157
TTM6.291YOY4.040+2.251
TTM6.2915Y5.058+1.233
5Y5.05810Y7.919-2.861
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of GlaxoSmithKline PLC ADR.

3.1. Institutions holding GlaxoSmithKline PLC ADR

Institutions are holding 14.533% of the shares of GlaxoSmithKline PLC ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Dodge & Cox3.40181.623769026793-254390-0.3672
2023-09-30FMR Inc0.8920.05671809951312911617.6817
2023-09-30Fisher Asset Management, LLC0.67030.279613600393-221437-1.6021
2023-12-31T. Rowe Price Associates, Inc.0.63180.063812818958521330.4083
2023-09-30JTC Employer Solutions Trustee Ltd0.613341.959212444460-1286460-9.3691
2023-12-31PRIMECAP Management Company0.59580.354712089370306000.2538
2023-09-30Royal Bank of Canada0.39820.079480798973898715.0698
2023-09-30Morgan Stanley - Brokerage Accounts0.37220.027875515551564802.116
2023-09-30State Street Corporation0.34780.01437058039-186654-2.5764
2023-09-30Goldman Sachs Group Inc0.25770.03815228301-3577952-40.6297
2023-09-30Holocene Advisors, LP0.24710.79585014059209622371.8417
2023-12-31Arrowstreet Capital Limited Partnership0.23750.18734819953-2982809-38.2276
2023-09-30Deutsche Bank AG0.21850.10384433524442500051912.2478
2023-12-31Provident Trust Company0.18322.82363716830129738553.6232
2023-12-31Equity Investment Corp0.15983.37633243259-34103-1.0406
2023-12-31Eversept Partners, LLC0.14659.67962972954-286388-8.7867
2023-09-30Camber Capital Management LLC0.14053.40542850000-1250000-30.4878
2023-09-30Hotchkis & Wiley Capital Management LLC0.13960.38942831916-33650-1.1743
2023-12-31Renaissance Technologies Corp0.13630.15862765193-146800-5.0412
2023-09-30Millennium Management LLC0.12930.04826241311510679135.6753
Total 9.919265.4651201269098+988889+0.5%

3.2. Funds holding GlaxoSmithKline PLC ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Dodge & Cox Stock I2.45571.83745004797700
2023-12-31Vanguard PRIMECAP Inv0.42460.45428654550240000.2781
2023-12-31Dodge & Cox Balanced I0.27051.4525551248000
2023-12-31Dodge & Cox Balanced Composite0.27051.4469551248000
2023-12-31T. Rowe Price International Val Eq Tr-D0.15971.04463254791795772.5062
2023-12-31T. Rowe Price International Value Equity0.15221.06323102406-45596-1.4484
2023-12-31T. Rowe Price International Value Eq0.15221.06743102406-45596-1.4484
2023-12-31T. Rowe Price International Core Eq Comp0.14980.47563053204-5700-0.1863
2023-12-31T. Rowe Price International Core Eq SMA0.14980.475630532043052809772863.038
2023-12-31T. Rowe Price Overseas Stock0.14980.47683053204-5700-0.1863
2024-01-31Fidelity Series Large Cap Stock0.13930.6844284002800
2024-01-31Clark Navigator International Equity/ADR0.08793.06821792275443102.5349
2023-12-31American Funds American Mutual A0.08510.07011734295-582-0.0335
2023-12-31Capital Group American Mutual Comp0.08510.07011734295-582-0.0335
2023-12-31T. Rowe Price International Core Eq Tr-A0.08420.4645171532957000.3334
2023-12-31Vanguard PRIMECAP Core Inv0.08340.52081700550482002.9171
2024-01-31Fidelity Growth & Income0.08170.6739166512800
2024-01-31Fidelity Equity Dividend Income0.08081.0881164720000
2023-12-31Vanguard Windsor™ II Inv0.07690.1026156791500
2024-01-31Strategic Advisers Fidelity US TtlStk0.07020.0583143152700
Total 5.209416.5952106175244+3150840+3.0%

3.3. Insider Transactions

Insiders are holding 0.053% of the shares of GlaxoSmithKline PLC ADR.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-05-20Plc GlaxosmithklineSELL3200526012.25

4. Summary

4.1. Key Performance Indicators

The key performance indicators of GlaxoSmithKline PLC ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---3.822-0.576-85%-1.747-54%0.082-4763%-0.023-99%
Book Value Per Share--3.9226.163-36%9.928-60%9.748-60%6.696-41%
Current Ratio--0.8850.915-3%1.126-21%0.910-3%0.940-6%
Debt To Asset Ratio--0.7830.795-1%0.795-2%0.7860%0.837-6%
Debt To Equity Ratio--3.4623.716-7%4.640-25%5.425-36%22.437-85%
Dividend Per Share--0.1740.285-39%0.537-68%0.535-67%0.585-70%
Eps--0.1070.682-84%2.232-95%1.042-90%1.060-90%
Free Cash Flow Per Share--0.6710.453+48%0.797-16%0.780-14%0.695-3%
Free Cash Flow To Equity Per Share---0.343-0.117-66%0.926-137%0.085-504%-0.145-58%
Gross Profit Margin--0.8140.954-15%1.000-19%0.991-18%0.995-18%
Intrinsic Value_10Y_max--17.597--------
Intrinsic Value_10Y_min---35.585--------
Intrinsic Value_1Y_max--2.635--------
Intrinsic Value_1Y_min--1.649--------
Intrinsic Value_3Y_max--7.253--------
Intrinsic Value_3Y_min--0.468--------
Intrinsic Value_5Y_max--11.070--------
Intrinsic Value_5Y_min---5.623--------
Market Cap87238317987.840-75%152538960000.00097728171250.000+56%69047876750.000+121%73233554258.725+108%71605694257.637+113%
Net Profit Margin--0.0430.166-74%0.151-71%0.151-71%0.144-70%
Operating Margin--0.1310.244-46%0.212-38%0.214-39%0.205-36%
Operating Ratio--0.8690.758+15%0.788+10%0.794+9%0.830+5%
Pb Ratio10.960+14%9.4486.291+50%4.040+134%5.058+87%7.919+19%
Pe Ratio100.167+14%86.35029.306+195%8.911+869%14.782+484%11.298+664%
Price Per Share42.990+14%37.06036.133+3%33.874+9%33.646+10%34.065+9%
Price To Free Cash Flow Ratio16.023+14%13.8133.893+255%11.420+21%-12.812+193%79.717-83%
Price To Total Gains Ratio-11.785-16%-10.159-2.595-74%24.516-141%34.120-130%1.508-774%
Quick Ratio--0.7040.800-12%0.784-10%0.604+17%0.584+21%
Return On Assets--0.0060.021-71%0.017-64%0.017-65%0.016-64%
Return On Equity--0.0260.098-73%0.096-73%0.110-76%0.283-91%
Total Gains Per Share---3.648-0.291-92%-1.210-67%0.617-691%0.561-750%
Usd Book Value--16144731000.00015420773250.000+5%20215297800.000-20%20382423210.000-21%13888064790.000+16%
Usd Book Value Change Per Share---3.822-0.576-85%-1.747-54%0.082-4763%-0.023-99%
Usd Book Value Per Share--3.9226.163-36%9.928-60%9.748-60%6.696-41%
Usd Dividend Per Share--0.1740.285-39%0.537-68%0.535-67%0.585-70%
Usd Eps--0.1070.682-84%2.232-95%1.042-90%1.060-90%
Usd Free Cash Flow--2760818400.0001324574550.000+108%1622990250.000+70%1667090160.000+66%1451164635.000+90%
Usd Free Cash Flow Per Share--0.6710.453+48%0.797-16%0.780-14%0.695-3%
Usd Free Cash Flow To Equity Per Share---0.343-0.117-66%0.926-137%0.085-504%-0.145-58%
Usd Market Cap87238317987.840-75%152538960000.00097728171250.000+56%69047876750.000+121%73233554258.725+108%71605694257.637+113%
Usd Price Per Share42.990+14%37.06036.133+3%33.874+9%33.646+10%34.065+9%
Usd Profit--441630000.0001554537600.000-72%1539396000.000-71%1551193830.000-72%1319590440.000-67%
Usd Revenue--10160013600.0009566967600.000+6%10067271300.000+1%10359945810.000-2%9464572530.000+7%
Usd Total Gains Per Share---3.648-0.291-92%-1.210-67%0.617-691%0.561-750%
 EOD+1 -7MRQTTM+10 -26YOY+7 -295Y+7 -2910Y+10 -26

4.2. Fundamental Score

Let's check the fundamental score of GlaxoSmithKline PLC ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15100.167
Price to Book Ratio (EOD)Between0-110.960
Net Profit Margin (MRQ)Greater than00.043
Operating Margin (MRQ)Greater than00.131
Quick Ratio (MRQ)Greater than10.704
Current Ratio (MRQ)Greater than10.885
Debt to Asset Ratio (MRQ)Less than10.783
Debt to Equity Ratio (MRQ)Less than13.462
Return on Equity (MRQ)Greater than0.150.026
Return on Assets (MRQ)Greater than0.050.006
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of GlaxoSmithKline PLC ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.638
Ma 20Greater thanMa 5042.643
Ma 50Greater thanMa 10041.580
Ma 100Greater thanMa 20038.970
OpenGreater thanClose42.580
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Tax Provision  1,262346,995348,257-42,901305,35618,927324,283-348,257-23,974
Income Tax Expense  1,262346,995348,257-42,901305,35618,927324,283-348,257-23,974



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in GBP. All numbers in thousands.

Summary
Total Assets59,005,000
Total Liabilities46,210,000
Total Stockholder Equity13,347,000
 As reported
Total Liabilities 46,210,000
Total Stockholder Equity+ 13,347,000
Total Assets = 59,005,000

Assets

Total Assets59,005,000
Total Current Assets18,644,000
Long-term Assets40,361,000
Total Current Assets
Cash And Cash Equivalents 2,936,000
Short-term Investments 2,246,000
Net Receivables 7,403,000
Inventory 5,498,000
Other Current Assets 561,000
Total Current Assets  (as reported)18,644,000
Total Current Assets  (calculated)18,644,000
+/-0
Long-term Assets
Property Plant Equipment 9,957,000
Goodwill 6,811,000
Intangible Assets 14,768,000
Long-term Assets Other 634,000
Long-term Assets  (as reported)40,361,000
Long-term Assets  (calculated)32,170,000
+/- 8,191,000

Liabilities & Shareholders' Equity

Total Current Liabilities21,068,000
Long-term Liabilities25,142,000
Total Stockholder Equity13,347,000
Total Current Liabilities
Short-term Debt 2,813,000
Short Long Term Debt 2,657,000
Accounts payable 15,844,000
Other Current Liabilities 1,911,000
Total Current Liabilities  (as reported)21,068,000
Total Current Liabilities  (calculated)23,225,000
+/- 2,157,000
Long-term Liabilities
Long term Debt 14,154,000
Capital Lease Obligations 1,207,000
Long-term Liabilities Other 5,609,000
Long-term Liabilities  (as reported)25,142,000
Long-term Liabilities  (calculated)20,970,000
+/- 4,172,000
Total Stockholder Equity
Common Stock1,348,000
Retained Earnings 7,239,000
Accumulated Other Comprehensive Income 1,597,000
Other Stockholders Equity 3,163,000
Total Stockholder Equity (as reported)13,347,000
Total Stockholder Equity (calculated)13,347,000
+/-0
Other
Capital Stock1,348,000
Cash and Short Term Investments 5,182,000
Common Stock Shares Outstanding 4,116,000
Current Deferred Revenue500,000
Liabilities and Stockholders Equity 59,005,000
Net Debt 15,082,000
Net Invested Capital 30,158,000
Net Working Capital -2,424,000
Property Plant and Equipment Gross 20,216,000
Short Long Term Debt Total 18,018,000



Balance Sheet

Currency in GBP. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-311991-12-311991-09-301991-06-301991-03-311990-12-311990-09-301990-06-301990-03-311989-12-311989-09-301989-06-301989-03-311988-12-311988-09-301988-06-301988-03-311987-12-311987-09-301987-06-301987-03-311986-12-311986-09-301986-06-301986-03-311985-12-311985-09-30
> Total Assets 
0
0
0
1,803,000
0
0
0
2,358,000
0
0
0
2,867,000
0
0
0
3,469,000
0
0
0
4,492,000
0
0
0
5,744,000
0
0
0
5,682,000
0
0
0
7,458,000
0
0
0
7,887,000
0
0
0
8,102,121
0
0
0
0
8,314,000
0
0
0
8,437,000
0
8,499,515
0
9,346,000
0
10,026,710
0
10,427,000
19,314,000
20,124,000
20,681,000
21,590,000
22,495,000
22,048,000
22,331,000
21,965,549
22,770,000
22,495,000
21,749,000
22,327,000
22,602,711
23,690,000
21,704,000
23,943,920
20,809,000
22,181,000
22,414,000
22,568,110
23,532,000
25,440,000
26,477,000
27,191,895
27,978,000
26,488,000
25,852,000
25,545,000
26,376,000
26,830,000
27,669,000
31,033,562
30,356,000
32,522,000
33,860,000
39,393,000
39,167,000
35,961,000
41,447,000
42,862,000
44,557,000
43,053,000
42,648,000
42,230,000
42,578,000
42,078,000
41,410,000
41,080,000
40,802,000
42,457,000
40,453,000
41,475,000
42,892,000
42,059,000
41,110,000
42,086,000
39,707,000
38,850,000
40,303,000
40,651,000
57,996,000
54,118,000
53,120,000
53,446,000
54,479,000
57,627,000
58,787,000
59,081,000
59,235,000
58,233,000
58,783,000
56,381,000
56,159,000
57,635,000
58,604,000
58,066,000
62,365,000
63,632,000
83,245,000
79,692,000
84,382,000
84,640,000
80,927,000
80,431,000
78,079,000
77,011,000
78,689,000
79,103,000
89,689,000
89,045,000
60,313,000
60,146,000
58,596,000
59,461,000
60,862,000
59,005,000
59,005,00060,862,00059,461,00058,596,00060,146,00060,313,00089,045,00089,689,00079,103,00078,689,00077,011,00078,079,00080,431,00080,927,00084,640,00084,382,00079,692,00083,245,00063,632,00062,365,00058,066,00058,604,00057,635,00056,159,00056,381,00058,783,00058,233,00059,235,00059,081,00058,787,00057,627,00054,479,00053,446,00053,120,00054,118,00057,996,00040,651,00040,303,00038,850,00039,707,00042,086,00041,110,00042,059,00042,892,00041,475,00040,453,00042,457,00040,802,00041,080,00041,410,00042,078,00042,578,00042,230,00042,648,00043,053,00044,557,00042,862,00041,447,00035,961,00039,167,00039,393,00033,860,00032,522,00030,356,00031,033,56227,669,00026,830,00026,376,00025,545,00025,852,00026,488,00027,978,00027,191,89526,477,00025,440,00023,532,00022,568,11022,414,00022,181,00020,809,00023,943,92021,704,00023,690,00022,602,71122,327,00021,749,00022,495,00022,770,00021,965,54922,331,00022,048,00022,495,00021,590,00020,681,00020,124,00019,314,00010,427,000010,026,71009,346,00008,499,51508,437,0000008,314,00000008,102,1210007,887,0000007,458,0000005,682,0000005,744,0000004,492,0000003,469,0000002,867,0000002,358,0000001,803,000000
   > Total Current Assets 
0
0
0
1,221,000
0
0
0
1,657,000
0
0
0
1,985,000
0
0
0
2,282,000
0
0
0
2,864,000
0
0
0
3,635,000
0
0
0
3,309,000
0
0
0
4,438,000
0
0
0
4,648,000
0
0
0
3,735,678
0
0
0
0
4,368,000
0
0
0
4,802,000
0
4,743,044
0
5,509,000
0
6,059,645
0
6,080,000
9,193,000
9,926,000
10,468,000
11,268,000
11,155,000
10,836,000
10,796,000
10,019,252
10,875,000
10,794,000
10,243,000
10,749,000
10,941,034
12,148,000
13,007,000
12,608,400
9,742,000
10,790,000
10,392,000
13,626,786
11,805,000
13,120,000
13,895,000
13,173,735
13,944,000
12,652,000
11,894,000
10,988,617
10,857,000
10,974,000
11,381,000
13,639,458
12,533,000
14,679,000
14,954,000
17,269,000
16,967,000
15,249,000
17,341,000
17,570,000
18,356,000
17,079,000
16,793,000
16,036,000
16,801,000
16,309,000
16,393,000
16,167,000
16,278,000
17,264,000
13,493,000
13,692,000
14,117,000
13,436,000
13,472,000
15,227,000
13,245,000
13,553,000
14,861,000
14,678,000
20,864,000
18,116,000
16,981,000
16,587,000
15,829,000
16,880,000
17,612,000
16,711,000
16,787,000
16,426,000
17,656,000
15,907,000
16,423,000
17,044,000
17,418,000
16,927,000
17,524,000
18,228,000
20,990,000
19,491,000
22,023,000
22,978,000
19,881,000
20,247,000
18,524,000
17,566,000
18,254,000
18,674,000
28,988,000
54,188,000
20,249,000
20,769,000
19,719,000
19,348,000
21,240,000
18,644,000
18,644,00021,240,00019,348,00019,719,00020,769,00020,249,00054,188,00028,988,00018,674,00018,254,00017,566,00018,524,00020,247,00019,881,00022,978,00022,023,00019,491,00020,990,00018,228,00017,524,00016,927,00017,418,00017,044,00016,423,00015,907,00017,656,00016,426,00016,787,00016,711,00017,612,00016,880,00015,829,00016,587,00016,981,00018,116,00020,864,00014,678,00014,861,00013,553,00013,245,00015,227,00013,472,00013,436,00014,117,00013,692,00013,493,00017,264,00016,278,00016,167,00016,393,00016,309,00016,801,00016,036,00016,793,00017,079,00018,356,00017,570,00017,341,00015,249,00016,967,00017,269,00014,954,00014,679,00012,533,00013,639,45811,381,00010,974,00010,857,00010,988,61711,894,00012,652,00013,944,00013,173,73513,895,00013,120,00011,805,00013,626,78610,392,00010,790,0009,742,00012,608,40013,007,00012,148,00010,941,03410,749,00010,243,00010,794,00010,875,00010,019,25210,796,00010,836,00011,155,00011,268,00010,468,0009,926,0009,193,0006,080,00006,059,64505,509,00004,743,04404,802,0000004,368,00000003,735,6780004,648,0000004,438,0000003,309,0000003,635,0000002,864,0000002,282,0000001,985,0000001,657,0000001,221,000000
       Cash And Cash Equivalents 
0
0
0
35,000
0
0
0
23,000
0
0
0
40,000
0
0
0
575,000
0
0
0
266,000
0
0
0
34,000
0
0
0
24,000
0
0
0
63,000
0
0
0
55,000
0
0
0
75,102
0
0
0
0
261,000
0
0
0
215,000
0
213,927
0
240,000
0
262,222
0
217,000
568,000
492,000
482,000
1,283,000
1,730,000
935,000
1,184,000
717,824
935,000
1,122,000
839,000
1,052,000
901,279
1,611,000
1,670,000
960,960
1,526,000
2,529,000
2,244,000
1,160,547
2,774,000
5,371,000
6,093,000
4,208,180
4,740,000
3,782,000
2,344,000
2,004,380
1,981,000
1,894,000
2,050,000
3,382,509
2,147,000
4,988,000
5,148,000
5,623,000
6,221,000
5,346,000
6,467,000
6,545,000
6,964,000
6,574,000
6,229,000
6,057,000
6,498,000
5,846,000
5,414,000
5,714,000
5,636,000
7,389,000
3,391,000
4,184,000
3,832,000
2,841,000
3,252,000
5,534,000
3,514,000
3,163,000
4,104,000
4,338,000
10,290,000
7,546,000
5,908,000
5,830,000
4,410,000
4,590,000
4,614,000
4,897,000
4,509,000
3,986,000
4,743,000
3,833,000
4,004,000
4,046,000
3,793,000
3,874,000
4,132,000
4,123,000
4,305,000
4,707,000
4,769,000
8,166,000
4,283,000
6,292,000
4,757,000
3,503,000
3,453,000
4,274,000
10,967,000
6,465,000
3,606,000
3,723,000
2,890,000
3,140,000
3,177,000
2,936,000
2,936,0003,177,0003,140,0002,890,0003,723,0003,606,0006,465,00010,967,0004,274,0003,453,0003,503,0004,757,0006,292,0004,283,0008,166,0004,769,0004,707,0004,305,0004,123,0004,132,0003,874,0003,793,0004,046,0004,004,0003,833,0004,743,0003,986,0004,509,0004,897,0004,614,0004,590,0004,410,0005,830,0005,908,0007,546,00010,290,0004,338,0004,104,0003,163,0003,514,0005,534,0003,252,0002,841,0003,832,0004,184,0003,391,0007,389,0005,636,0005,714,0005,414,0005,846,0006,498,0006,057,0006,229,0006,574,0006,964,0006,545,0006,467,0005,346,0006,221,0005,623,0005,148,0004,988,0002,147,0003,382,5092,050,0001,894,0001,981,0002,004,3802,344,0003,782,0004,740,0004,208,1806,093,0005,371,0002,774,0001,160,5472,244,0002,529,0001,526,000960,9601,670,0001,611,000901,2791,052,000839,0001,122,000935,000717,8241,184,000935,0001,730,0001,283,000482,000492,000568,000217,0000262,2220240,0000213,9270215,000000261,000000075,10200055,00000063,00000024,00000034,000000266,000000575,00000040,00000023,00000035,000000
       Short-term Investments 
0
0
0
557,000
0
0
0
912,000
0
0
0
1,132,000
0
0
0
719,000
0
0
0
1,326,000
0
0
0
2,095,000
0
0
0
1,725,000
0
0
0
2,434,000
0
0
0
2,708,000
0
0
0
0
0
0
0
0
1,001,000
0
0
0
1,447,000
0
0
0
1,645,000
0
0
0
1,749,000
1,612,000
68,000
68,000
2,309,000
829,000
154,000
149,000
1,603,576
1,548,000
152,000
137,000
1,417,000
1,475,394
164,000
159,000
2,489,760
1,460,000
1,452,000
1,493,000
2,816,908
1,490,000
288,000
336,000
1,024,585
1,039,000
997,000
1,043,000
1,034,601
1,009,000
1,022,000
1,084,000
1,154,228
1,225,000
393,000
401,000
391,000
622,000
573,000
562,000
397,000
341,000
359,000
431,000
277,000
170,000
166,000
170,000
184,000
203,000
204,000
226,000
81,000
83,000
72,000
67,000
66,000
65,000
64,000
67,000
69,000
73,000
69,000
71,000
75,000
77,000
83,000
85,000
89,000
88,000
85,000
82,000
78,000
76,000
81,000
80,000
84,000
81,000
84,000
86,000
79,000
86,000
87,000
83,000
78,000
60,000
59,000
61,000
61,000
3,010,000
67,000
3,555,000
4,154,000
4,085,000
3,364,000
3,506,000
2,246,000
2,246,0003,506,0003,364,0004,085,0004,154,0003,555,00067,0003,010,00061,00061,00059,00060,00078,00083,00087,00086,00079,00086,00084,00081,00084,00080,00081,00076,00078,00082,00085,00088,00089,00085,00083,00077,00075,00071,00069,00073,00069,00067,00064,00065,00066,00067,00072,00083,00081,000226,000204,000203,000184,000170,000166,000170,000277,000431,000359,000341,000397,000562,000573,000622,000391,000401,000393,0001,225,0001,154,2281,084,0001,022,0001,009,0001,034,6011,043,000997,0001,039,0001,024,585336,000288,0001,490,0002,816,9081,493,0001,452,0001,460,0002,489,760159,000164,0001,475,3941,417,000137,000152,0001,548,0001,603,576149,000154,000829,0002,309,00068,00068,0001,612,0001,749,0000001,645,0000001,447,0000001,001,000000000002,708,0000002,434,0000001,725,0000002,095,0000001,326,000000719,0000001,132,000000912,000000557,000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,032,516
0
0
0
0
0
0
0
0
0
0
2,386,006
0
0
0
2,553,942
0
0
0
0
0
0
0
0
0
5,602,880
0
0
0
0
0
0
0
6,888,000
0
0
0
7,306,339
0
0
0
5,107,815
5,338,000
4,993,000
0
5,501,199
5,223,000
5,232,000
5,123,000
5,558,348
5,802,000
5,724,000
5,533,000
6,341,000
6,015,000
5,418,000
6,102,000
6,550,000
6,866,000
6,057,000
6,034,000
5,849,000
0
0
0
0
0
0
0
0
0
0
0
5,281,000
0
0
0
4,486,000
0
0
0
5,488,000
0
5,999,000
7,251,000
5,917,000
6,451,000
6,392,000
6,730,000
5,950,000
8,998,596
8,951,242
9,846,094
25,644,448
6,551,000
6,875,000
8,173,000
6,441,000
8,895,000
7,496,000
8,421,000
-200,000
7,183,000
7,507,000
8,284,000
-200,000
8,300,000
6,870,000
8,094,000
7,115,000
7,129,000
7,095,000
8,874,000
7,403,000
7,403,0008,874,0007,095,0007,129,0007,115,0008,094,0006,870,0008,300,000-200,0008,284,0007,507,0007,183,000-200,0008,421,0007,496,0008,895,0006,441,0008,173,0006,875,0006,551,00025,644,4489,846,0948,951,2428,998,5965,950,0006,730,0006,392,0006,451,0005,917,0007,251,0005,999,00005,488,0000004,486,0000005,281,000000000000005,849,0006,034,0006,057,0006,866,0006,550,0006,102,0005,418,0006,015,0006,341,0005,533,0005,724,0005,802,0005,558,3485,123,0005,232,0005,223,0005,501,19904,993,0005,338,0005,107,8150007,306,3390006,888,00000000005,602,8800000000002,553,9420002,386,00600000000002,032,516000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
870,136
0
0
0
0
0
0
0
0
0
0
1,195,522
0
0
0
1,840,375
0
0
4,707,000
7,021,000
7,585,000
1,625,607
6,196,000
7,423,000
7,202,000
688
6,248,000
7,329,000
7,102,000
6,200,000
6,403,691
8,151,000
8,927,000
163,520
4,646,000
4,676,000
4,391,000
151,716
5,411,000
5,293,000
5,266,000
656,711
480,000
477,000
6,014,000
12,250
90,000
68,000
159,000
479,542
45,000
49,000
357,000
858,000
2,000
2,000
17,000
14,000
28,000
19,000
25,000
16,000
6,098,000
6,026,000
6,774,000
6,396,000
6,431,000
5,712,000
5,840,000
5,458,000
6,005,000
6,380,000
5,986,000
5,727,000
5,573,000
6,215,000
6,416,000
6,040,000
5,923,000
5,704,000
6,148,000
5,966,000
6,204,000
6,713,000
7,540,000
6,623,000
6,773,000
6,612,000
7,170,000
6,439,000
6,684,000
6,974,000
7,757,000
7,493,000
7,633,000
8,062,000
9,823,000
8,758,000
11,216,000
8,329,000
9,075,000
8,081,000
7,491,000
7,674,000
8,496,000
8,756,000
9,008,000
42,992,000
8,429,000
7,746,000
260,000
237,000
203,000
561,000
561,000203,000237,000260,0007,746,0008,429,00042,992,0009,008,0008,756,0008,496,0007,674,0007,491,0008,081,0009,075,0008,329,00011,216,0008,758,0009,823,0008,062,0007,633,0007,493,0007,757,0006,974,0006,684,0006,439,0007,170,0006,612,0006,773,0006,623,0007,540,0006,713,0006,204,0005,966,0006,148,0005,704,0005,923,0006,040,0006,416,0006,215,0005,573,0005,727,0005,986,0006,380,0006,005,0005,458,0005,840,0005,712,0006,431,0006,396,0006,774,0006,026,0006,098,00016,00025,00019,00028,00014,00017,0002,0002,000858,000357,00049,00045,000479,542159,00068,00090,00012,2506,014,000477,000480,000656,7115,266,0005,293,0005,411,000151,7164,391,0004,676,0004,646,000163,5208,927,0008,151,0006,403,6916,200,0007,102,0007,329,0006,248,0006887,202,0007,423,0006,196,0001,625,6077,585,0007,021,0004,707,000001,840,3750001,195,5220000000000870,136000000000000000000000000000000000000000
   > Long-term Assets 
0
0
0
582,000
0
0
0
701,000
0
0
0
882,000
0
0
0
1,187,000
0
0
0
1,628,000
0
0
0
2,109,000
0
0
0
2,373,000
0
0
0
3,020,000
0
0
0
3,239,000
0
0
0
4,366,444
0
0
0
0
3,946,000
0
0
0
3,635,000
0
3,756,471
0
3,837,000
0
3,967,065
0
4,347,000
10,121,000
10,198,000
10,213,000
10,322,000
11,340,000
11,212,000
11,535,000
11,946,296
11,895,000
11,701,000
11,506,000
11,578,000
11,661,678
11,542,000
8,697,000
11,335,520
11,067,000
11,391,000
12,022,000
8,941,324
11,727,000
12,320,000
12,582,000
14,018,160
14,034,000
13,836,000
13,958,000
14,556,383
15,519,000
15,856,000
16,288,000
17,394,104
17,823,000
17,843,000
18,906,000
22,124,000
22,200,000
20,712,000
24,106,000
25,292,000
26,201,000
25,974,000
25,855,000
26,194,000
25,777,000
25,769,000
25,017,000
24,913,000
24,524,000
25,193,000
26,960,000
27,783,000
28,775,000
28,623,000
27,638,000
26,859,000
26,462,000
25,297,000
25,442,000
25,973,000
37,132,000
36,002,000
36,139,000
36,859,000
38,650,000
40,747,000
41,175,000
42,370,000
42,448,000
41,807,000
41,127,000
40,474,000
39,736,000
40,591,000
41,186,000
41,139,000
44,841,000
45,404,000
62,255,000
60,201,000
62,359,000
61,662,000
61,046,000
60,184,000
59,555,000
59,445,000
60,435,000
60,429,000
60,701,000
34,857,000
40,064,000
39,377,000
38,877,000
40,113,000
39,622,000
40,361,000
40,361,00039,622,00040,113,00038,877,00039,377,00040,064,00034,857,00060,701,00060,429,00060,435,00059,445,00059,555,00060,184,00061,046,00061,662,00062,359,00060,201,00062,255,00045,404,00044,841,00041,139,00041,186,00040,591,00039,736,00040,474,00041,127,00041,807,00042,448,00042,370,00041,175,00040,747,00038,650,00036,859,00036,139,00036,002,00037,132,00025,973,00025,442,00025,297,00026,462,00026,859,00027,638,00028,623,00028,775,00027,783,00026,960,00025,193,00024,524,00024,913,00025,017,00025,769,00025,777,00026,194,00025,855,00025,974,00026,201,00025,292,00024,106,00020,712,00022,200,00022,124,00018,906,00017,843,00017,823,00017,394,10416,288,00015,856,00015,519,00014,556,38313,958,00013,836,00014,034,00014,018,16012,582,00012,320,00011,727,0008,941,32412,022,00011,391,00011,067,00011,335,5208,697,00011,542,00011,661,67811,578,00011,506,00011,701,00011,895,00011,946,29611,535,00011,212,00011,340,00010,322,00010,213,00010,198,00010,121,0004,347,00003,967,06503,837,00003,756,47103,635,0000003,946,00000004,366,4440003,239,0000003,020,0000002,373,0000002,109,0000001,628,0000001,187,000000882,000000701,000000582,000000
       Property Plant Equipment 
0
0
0
536,000
0
0
0
650,000
0
0
0
829,000
0
0
0
1,124,000
0
0
0
1,611,000
0
0
0
2,081,000
0
0
0
2,341,000
0
0
0
2,959,000
0
0
0
3,184,000
0
0
0
4,242,300
0
0
0
0
3,853,000
0
0
0
3,583,000
0
3,527,551
0
3,633,000
0
3,742,882
0
3,720,000
6,393,000
6,597,000
6,628,000
6,642,000
6,849,000
6,860,000
6,744,000
6,860,277
6,866,000
6,762,000
6,603,000
6,649,000
6,680,959
6,594,000
6,526,000
6,433,280
8,283,000
8,531,000
8,835,000
6,467,992
6,130,000
6,225,000
6,332,000
6,650,214
6,767,000
6,731,000
6,795,000
6,927,795
7,051,000
7,215,000
7,464,000
7,828,481
8,026,000
8,092,000
8,395,000
9,678,000
9,441,000
8,875,000
9,380,000
9,374,000
9,532,000
9,180,000
9,152,000
9,045,000
9,020,000
9,019,000
8,747,000
8,748,000
8,616,000
8,663,000
8,585,000
8,776,000
9,147,000
8,973,000
8,766,000
8,872,000
8,803,000
8,667,000
8,828,000
9,052,000
9,642,000
9,319,000
9,595,000
9,668,000
10,072,000
10,539,000
10,971,000
10,808,000
10,812,000
10,662,000
10,633,000
10,860,000
10,661,000
10,823,000
10,923,000
11,058,000
11,292,000
11,408,000
11,700,000
11,314,000
11,402,000
11,431,000
11,205,000
11,006,000
10,633,000
10,589,000
10,667,000
10,672,000
10,704,000
9,153,000
9,650,000
9,620,000
9,414,000
9,315,000
9,454,000
9,957,000
9,957,0009,454,0009,315,0009,414,0009,620,0009,650,0009,153,00010,704,00010,672,00010,667,00010,589,00010,633,00011,006,00011,205,00011,431,00011,402,00011,314,00011,700,00011,408,00011,292,00011,058,00010,923,00010,823,00010,661,00010,860,00010,633,00010,662,00010,812,00010,808,00010,971,00010,539,00010,072,0009,668,0009,595,0009,319,0009,642,0009,052,0008,828,0008,667,0008,803,0008,872,0008,766,0008,973,0009,147,0008,776,0008,585,0008,663,0008,616,0008,748,0008,747,0009,019,0009,020,0009,045,0009,152,0009,180,0009,532,0009,374,0009,380,0008,875,0009,441,0009,678,0008,395,0008,092,0008,026,0007,828,4817,464,0007,215,0007,051,0006,927,7956,795,0006,731,0006,767,0006,650,2146,332,0006,225,0006,130,0006,467,9928,835,0008,531,0008,283,0006,433,2806,526,0006,594,0006,680,9596,649,0006,603,0006,762,0006,866,0006,860,2776,744,0006,860,0006,849,0006,642,0006,628,0006,597,0006,393,0003,720,00003,742,88203,633,00003,527,55103,583,0000003,853,00000004,242,3000003,184,0000002,959,0000002,341,0000002,081,0000001,611,0000001,124,000000829,000000650,000000536,000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
254,235
0
0
0
253,048
241,000
242,000
257,000
275,225
251,061
252,894
151,000
142,800
244,720
244,701
246,024
266,324
303,000
304,000
334,000
1,196,285
692,000
685,000
679,000
757,959
946,000
956,000
985,000
1,371,560
1,372,000
1,618,000
1,747,000
2,101,000
2,147,000
2,015,000
3,294,000
3,361,000
3,524,000
3,545,000
3,484,000
3,606,000
3,712,000
3,750,000
3,745,000
3,754,000
3,659,000
3,722,000
4,405,000
4,359,000
4,550,000
4,499,000
4,316,000
4,205,000
4,169,000
3,666,000
3,733,000
3,724,000
5,212,000
5,072,000
5,165,000
5,162,000
5,392,000
5,747,000
5,865,000
5,965,000
5,960,000
5,864,000
5,764,000
5,734,000
7,866,573
5,778,000
5,848,000
5,789,000
6,807,000
7,026,000
11,046,000
10,562,000
10,899,000
10,998,000
10,888,000
10,597,000
10,442,000
10,435,000
10,582,000
10,552,000
10,705,000
5,906,000
7,195,000
7,046,000
6,857,000
6,716,000
6,973,000
6,811,000
6,811,0006,973,0006,716,0006,857,0007,046,0007,195,0005,906,00010,705,00010,552,00010,582,00010,435,00010,442,00010,597,00010,888,00010,998,00010,899,00010,562,00011,046,0007,026,0006,807,0005,789,0005,848,0005,778,0007,866,5735,734,0005,764,0005,864,0005,960,0005,965,0005,865,0005,747,0005,392,0005,162,0005,165,0005,072,0005,212,0003,724,0003,733,0003,666,0004,169,0004,205,0004,316,0004,499,0004,550,0004,359,0004,405,0003,722,0003,659,0003,754,0003,745,0003,750,0003,712,0003,606,0003,484,0003,545,0003,524,0003,361,0003,294,0002,015,0002,147,0002,101,0001,747,0001,618,0001,372,0001,371,560985,000956,000946,000757,959679,000685,000692,0001,196,285334,000304,000303,000266,324246,024244,701244,720142,800151,000252,894251,061275,225257,000242,000241,000253,048000254,235000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,526,000
0
0
0
1,454,000
0
0
0
1,462,000
0
1,590,000
1,202,000
1,248,000
1,325,000
1,263,000
1,116,000
1,109,000
1,612,360
1,667,762
2,105,126
6,741,048
41,978,798
28,066,891
22,894,175
64,262,568
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000064,262,56822,894,17528,066,89141,978,7986,741,0482,105,1261,667,7621,612,3601,109,0001,116,0001,263,0001,325,0001,248,0001,202,0001,590,00001,462,0000001,454,0000001,526,0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
117,969
0
106,000
0
157,105
0
144,000
1,126,000
1,162,000
1,161,000
1,136,000
1,818,000
1,781,000
1,750,000
1,851,339
1,834,000
1,798,000
1,775,000
1,808,000
1,859,401
1,839,000
1,710,000
1,694,560
2,308,000
2,324,000
2,648,000
2,141,226
2,508,000
2,592,000
2,641,000
4,078,000
3,354,000
3,227,000
3,194,000
3,292,145
3,702,000
3,688,000
3,721,000
4,460,596
4,492,000
4,658,000
4,944,000
5,869,000
6,157,000
5,787,000
7,261,000
8,183,000
8,412,000
8,378,000
8,369,000
8,532,000
8,580,000
8,499,000
7,847,000
7,802,000
7,605,000
7,674,000
8,777,000
10,161,000
10,356,000
10,276,000
9,865,000
9,283,000
9,050,000
8,413,000
8,370,000
8,320,000
17,084,000
16,614,000
16,668,000
16,672,000
17,644,000
18,317,000
18,471,000
18,776,000
18,753,000
18,465,000
17,921,000
17,562,000
24,283,708
17,294,000
17,263,000
17,202,000
20,022,000
20,134,000
32,455,000
30,955,000
31,499,000
31,263,000
30,664,000
29,824,000
29,418,000
29,333,000
30,241,000
30,079,000
30,468,000
11,371,000
15,589,000
14,318,000
14,160,000
15,531,000
15,295,000
14,768,000
14,768,00015,295,00015,531,00014,160,00014,318,00015,589,00011,371,00030,468,00030,079,00030,241,00029,333,00029,418,00029,824,00030,664,00031,263,00031,499,00030,955,00032,455,00020,134,00020,022,00017,202,00017,263,00017,294,00024,283,70817,562,00017,921,00018,465,00018,753,00018,776,00018,471,00018,317,00017,644,00016,672,00016,668,00016,614,00017,084,0008,320,0008,370,0008,413,0009,050,0009,283,0009,865,00010,276,00010,356,00010,161,0008,777,0007,674,0007,605,0007,802,0007,847,0008,499,0008,580,0008,532,0008,369,0008,378,0008,412,0008,183,0007,261,0005,787,0006,157,0005,869,0004,944,0004,658,0004,492,0004,460,5963,721,0003,688,0003,702,0003,292,1453,194,0003,227,0003,354,0004,078,0002,641,0002,592,0002,508,0002,141,2262,648,0002,324,0002,308,0001,694,5601,710,0001,839,0001,859,4011,808,0001,775,0001,798,0001,834,0001,851,3391,750,0001,781,0001,818,0001,136,0001,161,0001,162,0001,126,000144,0000157,1050106,0000117,96900000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,682,000
0
5,503,440
0
6,136,000
7,043,000
7,380,573
7,141,000
7,508,000
7,697,000
7,933,226
7,880,789
8,178,549
8,242,782
8,758,638
3,808,800
3,786,521
4,536,972
4,740,184
10,309,070
10,679,108
10,814,026
12,665,837
12,639,493
13,137,856
13,406,270
14,946,077
16,669,258
17,336,439
17,991,251
18,961,971
19,451,944
19,410,341
18,713,785
18,194,808
18,245,370
19,474,232
23,567,491
25,734,630
25,313,543
25,101,992
26,275,489
26,395,740
26,891,633
26,912,226
25,420,248
25,115,560
25,428,940
25,928,958
29,642,550
30,909,184
29,820,821
29,887,650
30,533,009
29,811,653
29,446,382
28,445,617
26,947,908
26,359,534
40,822,650
41,964,354
40,123,910
40,095,849
41,098,022
40,001,433
39,310,506
38,938,039
39,662,054
40,472,929
40,868,059
40,064,780
7,073,034
7,132,343
7,223,164
23,837,347
5,078,000
5,147,000
5,128,000
5,214,000
6,368,000
5,406,000
5,317,000
5,261,000
5,301,000
5,847,000
6,121,000
6,894,000
7,069,000
6,688,000
5,988,000
6,852,000
7,106,000
7,201,000
6,758,000
0
06,758,0007,201,0007,106,0006,852,0005,988,0006,688,0007,069,0006,894,0006,121,0005,847,0005,301,0005,261,0005,317,0005,406,0006,368,0005,214,0005,128,0005,147,0005,078,00023,837,3477,223,1647,132,3437,073,03440,064,78040,868,05940,472,92939,662,05438,938,03939,310,50640,001,43341,098,02240,095,84940,123,91041,964,35440,822,65026,359,53426,947,90828,445,61729,446,38229,811,65330,533,00929,887,65029,820,82130,909,18429,642,55025,928,95825,428,94025,115,56025,420,24826,912,22626,891,63326,395,74026,275,48925,101,99225,313,54325,734,63023,567,49119,474,23218,245,37018,194,80818,713,78519,410,34119,451,94418,961,97117,991,25117,336,43916,669,25814,946,07713,406,27013,137,85612,639,49312,665,83710,814,02610,679,10810,309,0704,740,1844,536,9723,786,5213,808,8008,758,6388,242,7828,178,5497,880,7897,933,2267,697,0007,508,0007,141,0007,380,5737,043,0006,136,00005,503,44001,682,0000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
703,000
0
0
0
894,000
0
0
0
1,064,000
0
0
0
1,156,000
0
0
0
1,687,000
0
0
0
2,462,000
0
0
0
2,043,000
0
0
0
2,801,000
0
0
0
2,738,000
0
0
0
7,527,431
0
0
0
0
7,047,000
0
0
0
6,547,000
0
6,194,475
0
6,578,000
0
6,827,292
0
7,234,000
12,131,000
12,563,000
12,558,000
12,635,000
13,843,000
12,887,000
13,110,000
13,568,454
14,598,000
14,947,000
14,449,000
14,939,000
14,654,151
15,204,000
15,550,000
15,489,600
16,218,000
13,548,000
13,879,000
16,368,619
17,277,000
18,855,000
19,299,000
19,623,449
18,923,000
17,454,000
16,448,000
15,900,292
16,214,000
15,789,000
17,507,000
21,113,956
21,146,000
24,815,000
26,063,000
31,075,000
30,733,000
27,930,000
31,813,000
32,120,000
33,131,000
33,509,000
32,035,000
32,485,000
32,691,000
32,643,000
33,179,000
32,253,000
31,226,000
34,661,000
33,425,000
34,728,000
35,275,000
34,788,000
34,309,000
34,274,000
32,276,000
32,014,000
34,553,000
35,715,000
46,588,000
43,566,000
43,789,000
44,568,000
47,938,000
53,401,000
54,789,000
54,118,000
53,642,000
53,809,000
53,954,000
52,892,000
52,569,000
54,612,000
54,881,000
54,394,000
58,994,000
60,665,000
65,185,000
61,335,000
64,285,000
64,503,000
60,302,000
59,623,000
57,069,000
55,433,000
56,941,000
57,761,000
67,057,000
66,405,000
51,597,000
50,050,000
47,284,000
47,302,000
48,243,000
46,210,000
46,210,00048,243,00047,302,00047,284,00050,050,00051,597,00066,405,00067,057,00057,761,00056,941,00055,433,00057,069,00059,623,00060,302,00064,503,00064,285,00061,335,00065,185,00060,665,00058,994,00054,394,00054,881,00054,612,00052,569,00052,892,00053,954,00053,809,00053,642,00054,118,00054,789,00053,401,00047,938,00044,568,00043,789,00043,566,00046,588,00035,715,00034,553,00032,014,00032,276,00034,274,00034,309,00034,788,00035,275,00034,728,00033,425,00034,661,00031,226,00032,253,00033,179,00032,643,00032,691,00032,485,00032,035,00033,509,00033,131,00032,120,00031,813,00027,930,00030,733,00031,075,00026,063,00024,815,00021,146,00021,113,95617,507,00015,789,00016,214,00015,900,29216,448,00017,454,00018,923,00019,623,44919,299,00018,855,00017,277,00016,368,61913,879,00013,548,00016,218,00015,489,60015,550,00015,204,00014,654,15114,939,00014,449,00014,947,00014,598,00013,568,45413,110,00012,887,00013,843,00012,635,00012,558,00012,563,00012,131,0007,234,00006,827,29206,578,00006,194,47506,547,0000007,047,00000007,527,4310002,738,0000002,801,0000002,043,0000002,462,0000001,687,0000001,156,0000001,064,000000894,000000703,000000
   > Total Current Liabilities 
0
0
0
559,000
0
0
0
711,000
0
0
0
869,000
0
0
0
863,000
0
0
0
1,406,000
0
0
0
2,027,000
0
0
0
1,568,000
0
0
0
2,200,000
0
0
0
2,130,000
0
0
0
3,167,957
0
0
0
0
4,154,000
0
0
0
3,886,000
0
3,530,549
0
4,145,000
0
4,540,518
0
5,263,000
8,330,000
8,693,000
8,737,000
9,084,000
9,618,000
8,813,000
9,072,000
9,450,774
9,514,000
9,867,000
8,958,000
8,808,000
8,461,411
8,041,000
8,391,000
8,585,360
8,700,000
7,816,000
7,012,000
8,718,182
9,140,000
9,142,000
9,431,000
9,508,940
9,346,000
8,248,000
7,293,000
7,262,624
7,442,000
7,207,000
9,029,000
10,355,278
9,279,000
8,266,000
8,798,000
10,017,000
9,746,000
9,034,000
11,120,000
12,118,000
12,153,000
12,002,000
11,243,000
12,794,000
13,111,000
13,621,000
13,106,000
15,010,000
14,533,000
15,402,000
13,964,000
13,815,000
12,008,000
12,477,000
12,832,000
13,677,000
11,667,000
12,252,000
15,270,000
13,295,000
15,786,000
13,796,000
12,750,000
13,417,000
13,919,000
18,107,000
18,137,000
19,001,000
18,757,000
28,788,000
27,438,000
26,569,000
26,927,000
18,198,000
18,395,000
22,491,000
24,460,000
25,779,000
25,514,000
24,050,000
25,335,000
23,924,000
22,179,000
22,148,000
20,275,000
21,387,000
22,417,000
23,670,000
24,278,000
37,835,000
20,953,000
22,810,000
20,696,000
22,108,000
22,390,000
21,068,000
21,068,00022,390,00022,108,00020,696,00022,810,00020,953,00037,835,00024,278,00023,670,00022,417,00021,387,00020,275,00022,148,00022,179,00023,924,00025,335,00024,050,00025,514,00025,779,00024,460,00022,491,00018,395,00018,198,00026,927,00026,569,00027,438,00028,788,00018,757,00019,001,00018,137,00018,107,00013,919,00013,417,00012,750,00013,796,00015,786,00013,295,00015,270,00012,252,00011,667,00013,677,00012,832,00012,477,00012,008,00013,815,00013,964,00015,402,00014,533,00015,010,00013,106,00013,621,00013,111,00012,794,00011,243,00012,002,00012,153,00012,118,00011,120,0009,034,0009,746,00010,017,0008,798,0008,266,0009,279,00010,355,2789,029,0007,207,0007,442,0007,262,6247,293,0008,248,0009,346,0009,508,9409,431,0009,142,0009,140,0008,718,1827,012,0007,816,0008,700,0008,585,3608,391,0008,041,0008,461,4118,808,0008,958,0009,867,0009,514,0009,450,7749,072,0008,813,0009,618,0009,084,0008,737,0008,693,0008,330,0005,263,00004,540,51804,145,00003,530,54903,886,0000004,154,00000003,167,9570002,130,0000002,200,0000001,568,0000002,027,0000001,406,000000863,000000869,000000711,000000559,000000
       Short-term Debt 
0
0
0
106,000
0
0
0
197,000
0
0
0
252,000
0
0
0
142,000
0
0
0
425,000
0
0
0
871,000
0
0
0
366,000
0
0
0
597,000
0
0
0
400,000
0
0
0
919,179
0
0
0
0
1,546,000
0
0
0
1,181,000
0
1,256,455
0
1,317,000
0
1,963,498
0
2,250,000
3,018,000
3,100,000
3,050,000
2,281,000
2,353,000
1,983,000
1,892,000
2,128,695
2,051,000
2,525,000
1,751,000
1,551,000
1,324,444
1,372,000
1,596,000
1,449,840
1,394,000
1,096,000
1,157,000
1,581,285
1,686,000
1,708,000
1,616,000
2,094,501
863,000
556,000
653,000
717,636
1,205,000
1,175,000
1,994,000
3,507,563
1,799,000
1,157,000
1,387,000
956,000
1,276,000
1,185,000
1,886,000
1,471,000
1,034,000
453,000
386,000
291,000
258,000
1,039,000
872,000
2,698,000
2,723,000
3,657,000
4,155,000
3,631,000
2,023,000
2,334,000
2,752,000
2,789,000
1,857,000
3,143,000
5,340,000
2,943,000
3,240,000
2,472,000
1,422,000
1,308,000
1,233,000
4,485,000
3,961,000
4,129,000
3,740,000
6,612,000
4,740,000
2,825,000
3,442,000
3,470,000
2,902,000
5,793,000
8,413,000
10,147,000
8,216,000
6,918,000
7,265,000
5,964,000
4,914,000
3,725,000
3,172,000
5,041,000
4,869,000
3,601,000
4,102,000
3,327,000
2,793,000
3,952,000
4,261,000
5,921,000
4,843,000
2,813,000
2,813,0004,843,0005,921,0004,261,0003,952,0002,793,0003,327,0004,102,0003,601,0004,869,0005,041,0003,172,0003,725,0004,914,0005,964,0007,265,0006,918,0008,216,00010,147,0008,413,0005,793,0002,902,0003,470,0003,442,0002,825,0004,740,0006,612,0003,740,0004,129,0003,961,0004,485,0001,233,0001,308,0001,422,0002,472,0003,240,0002,943,0005,340,0003,143,0001,857,0002,789,0002,752,0002,334,0002,023,0003,631,0004,155,0003,657,0002,723,0002,698,000872,0001,039,000258,000291,000386,000453,0001,034,0001,471,0001,886,0001,185,0001,276,000956,0001,387,0001,157,0001,799,0003,507,5631,994,0001,175,0001,205,000717,636653,000556,000863,0002,094,5011,616,0001,708,0001,686,0001,581,2851,157,0001,096,0001,394,0001,449,8401,596,0001,372,0001,324,4441,551,0001,751,0002,525,0002,051,0002,128,6951,892,0001,983,0002,353,0002,281,0003,050,0003,100,0003,018,0002,250,00001,963,49801,317,00001,256,45501,181,0000001,546,0000000919,179000400,000000597,000000366,000000871,000000425,000000142,000000252,000000197,000000106,000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,245,000
0
0
0
1,949,000
0
0
0
941,000
0
19,583,000
19,362,000
2,720,000
18,340,000
18,871,000
19,034,000
2,040,000
24,518,258
41,599,129,916,930
0
5,895,721
0
0
0
6,678,000
0
492,000
0
3,495,000
0
0
0
3,398,000
0
0
0
3,785,000
0
0
0
2,657,000
2,657,0000003,785,0000003,398,0000003,495,0000492,00006,678,0000005,895,721041,599,129,916,93024,518,2582,040,00019,034,00018,871,00018,340,0002,720,00019,362,00019,583,0000941,0000001,949,00000018,245,0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
57,000
0
0
0
76,000
0
0
0
95,000
0
0
0
113,000
0
0
0
134,000
0
0
0
146,000
0
0
0
162,000
0
0
0
178,000
0
0
0
188,000
0
0
0
2,248,779
0
0
0
0
270,000
0
0
0
299,000
0
1,154,500
0
293,000
0
299,248
0
367,000
5,312,000
5,593,000
5,687,000
812,000
7,265,000
6,830,000
7,180,000
761,871
7,463,000
7,342,000
7,207,000
715,000
7,136,967
6,669,000
6,795,000
684,880
7,306,000
3,917,000
4,173,000
706,443
4,155,000
4,272,000
4,579,000
818,854
4,931,000
4,493,000
4,611,000
864,635
4,534,000
4,374,000
5,142,000
4,866,013
5,329,000
5,312,000
5,143,000
6,075,000
5,752,000
5,161,000
6,084,000
6,772,000
6,796,000
6,568,000
6,806,000
6,888,000
7,246,000
7,268,000
7,174,000
7,359,000
7,058,000
7,160,000
7,683,000
8,054,000
7,713,000
7,836,000
7,795,000
8,317,000
7,300,000
6,949,000
7,541,000
7,958,000
8,592,000
8,155,000
8,514,000
9,191,000
10,362,000
10,880,000
11,714,000
11,964,000
12,033,000
19,580,000
19,840,000
20,970,000
21,088,000
12,545,000
13,093,000
14,037,000
13,424,000
13,385,000
14,737,000
14,939,000
15,310,000
15,450,000
15,142,000
15,840,000
14,610,000
14,267,000
15,230,000
17,554,000
17,577,000
14,806,000
16,115,000
16,263,000
14,268,000
13,951,000
15,582,000
15,844,000
15,844,00015,582,00013,951,00014,268,00016,263,00016,115,00014,806,00017,577,00017,554,00015,230,00014,267,00014,610,00015,840,00015,142,00015,450,00015,310,00014,939,00014,737,00013,385,00013,424,00014,037,00013,093,00012,545,00021,088,00020,970,00019,840,00019,580,00012,033,00011,964,00011,714,00010,880,00010,362,0009,191,0008,514,0008,155,0008,592,0007,958,0007,541,0006,949,0007,300,0008,317,0007,795,0007,836,0007,713,0008,054,0007,683,0007,160,0007,058,0007,359,0007,174,0007,268,0007,246,0006,888,0006,806,0006,568,0006,796,0006,772,0006,084,0005,161,0005,752,0006,075,0005,143,0005,312,0005,329,0004,866,0135,142,0004,374,0004,534,000864,6354,611,0004,493,0004,931,000818,8544,579,0004,272,0004,155,000706,4434,173,0003,917,0007,306,000684,8806,795,0006,669,0007,136,967715,0007,207,0007,342,0007,463,000761,8717,180,0006,830,0007,265,000812,0005,687,0005,593,0005,312,000367,0000299,2480293,00001,154,5000299,000000270,00000002,248,779000188,000000178,000000162,000000146,000000134,000000113,00000095,00000076,00000057,000000
       Other Current Liabilities 
0
0
0
396,000
0
0
0
438,000
0
0
0
522,000
0
0
0
608,000
0
0
0
847,000
0
0
0
1,010,000
0
0
0
1,040,000
0
0
0
1,425,000
0
0
0
1,542,000
0
0
0
0
0
0
0
0
2,338,000
0
0
0
2,406,000
0
1,119,595
0
2,535,000
0
2,277,772
0
2,646,000
0
4,474,000
0
5,991,000
0
9,630,000
10,554,000
3,411,556
10,597,000
11,160,000
11,315,000
6,542,000
11,293,008
11,023,190
11,456,353
3,333,680
13,163,360
996,000
1,682,000
3,322,106
3,299,000
3,162,000
3,236,000
6,561,878
3,552,000
3,199,000
2,029,000
2,809,297
1,703,000
1,658,000
1,893,000
1,719,493
2,151,000
1,797,000
195,000
752,000
254,000
400,000
241,000
168,000
127,000
209,000
231,000
188,000
5,607,000
5,314,000
5,060,000
9,744,000
4,752,000
4,585,000
2,126,000
7,518,000
2,272,000
2,307,000
2,285,000
8,149,000
2,510,000
2,160,000
2,389,000
7,562,000
3,954,000
3,169,000
2,814,000
8,989,000
2,324,000
2,742,000
2,462,000
561,000
595,000
855,000
917,000
1,076,000
732,000
806,000
818,000
837,000
830,000
816,000
838,000
755,000
796,000
804,000
776,000
765,000
746,000
743,000
765,000
958,000
2,599,000
19,702,000
2,045,000
2,595,000
2,167,000
947,000
1,024,000
1,911,000
1,911,0001,024,000947,0002,167,0002,595,0002,045,00019,702,0002,599,000958,000765,000743,000746,000765,000776,000804,000796,000755,000838,000816,000830,000837,000818,000806,000732,0001,076,000917,000855,000595,000561,0002,462,0002,742,0002,324,0008,989,0002,814,0003,169,0003,954,0007,562,0002,389,0002,160,0002,510,0008,149,0002,285,0002,307,0002,272,0007,518,0002,126,0004,585,0004,752,0009,744,0005,060,0005,314,0005,607,000188,000231,000209,000127,000168,000241,000400,000254,000752,000195,0001,797,0002,151,0001,719,4931,893,0001,658,0001,703,0002,809,2972,029,0003,199,0003,552,0006,561,8783,236,0003,162,0003,299,0003,322,1061,682,000996,00013,163,3603,333,68011,456,35311,023,19011,293,0086,542,00011,315,00011,160,00010,597,0003,411,55610,554,0009,630,00005,991,00004,474,00002,646,00002,277,77202,535,00001,119,59502,406,0000002,338,000000000001,542,0000001,425,0000001,040,0000001,010,000000847,000000608,000000522,000000438,000000396,000000
   > Long-term Liabilities 
0
0
0
144,000
0
0
0
183,000
0
0
0
195,000
0
0
0
293,000
0
0
0
281,000
0
0
0
435,000
0
0
0
475,000
0
0
0
601,000
0
0
0
608,000
0
0
0
4,359,473
0
0
0
0
2,893,000
0
0
0
2,661,000
0
2,663,925
0
2,433,000
0
2,286,775
0
1,971,000
3,801,000
3,870,000
3,821,000
3,551,000
4,225,000
4,074,000
4,038,000
4,117,680
5,084,000
5,080,000
5,491,000
6,131,000
6,192,740
7,163,000
7,159,000
6,904,240
7,518,000
5,732,000
6,867,000
7,650,437
8,137,000
9,713,000
9,868,000
10,114,509
9,577,000
9,206,000
9,155,000
8,637,668
8,772,000
8,582,000
8,478,000
10,758,678
11,867,000
16,549,000
17,265,000
21,058,000
20,987,000
18,896,000
20,693,000
20,002,000
20,978,000
21,507,000
20,792,000
19,691,000
19,580,000
19,022,000
20,073,000
17,243,000
16,693,000
19,259,000
19,461,000
20,913,000
23,267,000
22,311,000
21,477,000
20,597,000
20,609,000
19,762,000
19,283,000
22,420,000
30,802,000
29,770,000
31,039,000
31,151,000
34,019,000
35,294,000
36,652,000
35,117,000
34,885,000
25,021,000
26,516,000
26,323,000
25,642,000
36,414,000
36,486,000
31,903,000
34,534,000
34,886,000
39,671,000
37,285,000
38,950,000
40,579,000
38,123,000
37,475,000
36,794,000
34,046,000
34,524,000
34,091,000
42,779,000
28,570,000
30,644,000
27,240,000
26,588,000
25,194,000
25,853,000
25,142,000
25,142,00025,853,00025,194,00026,588,00027,240,00030,644,00028,570,00042,779,00034,091,00034,524,00034,046,00036,794,00037,475,00038,123,00040,579,00038,950,00037,285,00039,671,00034,886,00034,534,00031,903,00036,486,00036,414,00025,642,00026,323,00026,516,00025,021,00034,885,00035,117,00036,652,00035,294,00034,019,00031,151,00031,039,00029,770,00030,802,00022,420,00019,283,00019,762,00020,609,00020,597,00021,477,00022,311,00023,267,00020,913,00019,461,00019,259,00016,693,00017,243,00020,073,00019,022,00019,580,00019,691,00020,792,00021,507,00020,978,00020,002,00020,693,00018,896,00020,987,00021,058,00017,265,00016,549,00011,867,00010,758,6788,478,0008,582,0008,772,0008,637,6689,155,0009,206,0009,577,00010,114,5099,868,0009,713,0008,137,0007,650,4376,867,0005,732,0007,518,0006,904,2407,159,0007,163,0006,192,7406,131,0005,491,0005,080,0005,084,0004,117,6804,038,0004,074,0004,225,0003,551,0003,821,0003,870,0003,801,0001,971,00002,286,77502,433,00002,663,92502,661,0000002,893,00000004,359,473000608,000000601,000000475,000000435,000000281,000000293,000000195,000000183,000000144,000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,524,974
23,344,000
23,313,000
24,833,000
23,590,000
24,741,000
25,726,000
23,334,000
23,425,000
23,047,000
20,442,000
20,736,000
20,572,000
29,226,000
18,784,000
19,322,000
17,035,000
16,644,000
15,553,000
15,993,000
0
015,993,00015,553,00016,644,00017,035,00019,322,00018,784,00029,226,00020,572,00020,736,00020,442,00023,047,00023,425,00023,334,00025,726,00024,741,00023,590,00024,833,00023,313,00023,344,00068,524,974000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,092,000
0
2,691,900
0
2,780,000
2,911,000
2,908,600
3,713,000
4,066,000
4,404,000
3,697,022
5,134,908
5,500,851
5,746,483
4,738,835
5,486,880
5,570,120
5,913,621
4,910,708
6,459,696
6,972,977
7,202,272
7,351,308
6,287,570
6,800,990
6,954,866
6,410,498
6,391,720
5,300,645
5,631,441
5,544,134
5,487,922
6,411,723
6,786,885
7,474,695
7,384,520
8,772,206
7,949,187
7,389,936
7,731,193
8,954,748
8,235,179
6,426,160
6,449,691
6,545,696
7,927,618
6,553,506
6,197,385
7,624,965
8,540,281
8,518,036
7,509,901
7,585,227
7,772,392
7,372,115
7,573,785
7,794,748
8,160,282
9,555,545
20,503,395
21,000,263
21,507,045
21,094,154
23,925,670
24,479,161
25,374,043
22,850,592
22,967,785
14,022,905
13,812,101
14,425,973
16,330,056
15,536,864
15,231,512
50,167,544
14,660,029
11,573,000
14,838,000
13,695,000
14,209,000
14,853,000
14,789,000
14,050,000
13,747,000
13,604,000
13,788,000
13,519,000
13,530,000
9,785,000
11,321,000
10,205,000
9,944,000
0
9,854,000
0
09,854,00009,944,00010,205,00011,321,0009,785,00013,530,00013,519,00013,788,00013,604,00013,747,00014,050,00014,789,00014,853,00014,209,00013,695,00014,838,00011,573,00014,660,02950,167,54415,231,51215,536,86416,330,05614,425,97313,812,10114,022,90522,967,78522,850,59225,374,04324,479,16123,925,67021,094,15421,507,04521,000,26320,503,3959,555,5458,160,2827,794,7487,573,7857,372,1157,772,3927,585,2277,509,9018,518,0368,540,2817,624,9656,197,3856,553,5067,927,6186,545,6966,449,6916,426,1608,235,1798,954,7487,731,1937,389,9367,949,1878,772,2067,384,5207,474,6956,786,8856,411,7235,487,9225,544,1345,631,4415,300,6456,391,7206,410,4986,954,8666,800,9906,287,5707,351,3087,202,2726,972,9776,459,6964,910,7085,913,6215,570,1205,486,8804,738,8355,746,4835,500,8515,134,9083,697,0224,404,0004,066,0003,713,0002,908,6002,911,0002,780,00002,691,90001,092,0000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
694,000
0
0
0
2,243,000
0
0
0
2,390,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000002,390,0000002,243,000000694,00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
1,090,000
0
0
0
1,450,000
0
0
0
1,784,000
0
0
0
2,291,000
0
0
0
2,732,000
0
0
0
3,208,000
0
0
0
3,572,000
0
0
0
4,546,000
0
0
0
5,026,000
0
0
0
410,484
0
0
0
0
1,225,000
0
0
0
1,843,000
0
2,247,046
0
2,702,000
0
3,145,401
0
3,142,000
6,068,000
6,365,000
6,888,000
7,711,000
7,854,000
8,353,000
8,408,000
7,533,366
7,338,000
6,750,000
6,501,000
6,581,000
7,167,915
7,727,000
5,369,000
7,710,080
4,335,000
5,178,000
4,957,000
5,922,650
6,079,000
6,397,000
6,945,000
7,309,249
8,818,000
8,815,000
9,162,000
9,382,867
9,935,000
10,796,000
9,879,000
9,612,518
8,916,000
7,438,000
7,486,000
7,931,000
8,062,000
7,717,000
9,280,000
10,005,000
10,670,000
8,769,000
9,809,000
8,887,000
9,071,000
8,681,000
7,443,000
8,032,000
8,776,000
7,052,000
6,223,000
5,810,000
6,694,000
6,412,000
5,974,000
6,997,000
6,616,000
6,118,000
5,043,000
4,263,000
7,434,000
6,820,000
5,431,000
5,114,000
2,808,000
574,000
138,000
1,124,000
1,714,000
811,000
1,294,000
-68,000
-69,000
3,679,000
4,476,000
4,360,000
4,014,000
3,614,000
11,772,000
11,984,000
13,094,000
13,593,000
14,286,000
14,587,000
14,865,000
15,377,000
15,426,000
15,055,000
16,181,000
16,374,000
9,152,000
10,598,000
11,820,000
12,691,000
13,133,000
13,347,000
13,347,00013,133,00012,691,00011,820,00010,598,0009,152,00016,374,00016,181,00015,055,00015,426,00015,377,00014,865,00014,587,00014,286,00013,593,00013,094,00011,984,00011,772,0003,614,0004,014,0004,360,0004,476,0003,679,000-69,000-68,0001,294,000811,0001,714,0001,124,000138,000574,0002,808,0005,114,0005,431,0006,820,0007,434,0004,263,0005,043,0006,118,0006,616,0006,997,0005,974,0006,412,0006,694,0005,810,0006,223,0007,052,0008,776,0008,032,0007,443,0008,681,0009,071,0008,887,0009,809,0008,769,00010,670,00010,005,0009,280,0007,717,0008,062,0007,931,0007,486,0007,438,0008,916,0009,612,5189,879,00010,796,0009,935,0009,382,8679,162,0008,815,0008,818,0007,309,2496,945,0006,397,0006,079,0005,922,6504,957,0005,178,0004,335,0007,710,0805,369,0007,727,0007,167,9156,581,0006,501,0006,750,0007,338,0007,533,3668,408,0008,353,0007,854,0007,711,0006,888,0006,365,0006,068,0003,142,00003,145,40102,702,00002,247,04601,843,0000001,225,0000000410,4840005,026,0000004,546,0000003,572,0000003,208,0000002,732,0000002,291,0000001,784,0000001,450,0000001,090,000000
   Common Stock
0
0
0
370,000
0
0
0
370,000
0
0
0
370,000
0
0
0
372,000
0
0
0
747,000
0
0
0
750,000
0
0
0
753,000
0
0
0
758,000
0
0
0
762,000
0
0
0
0
0
0
0
0
886,000
0
0
0
894,000
0
0
0
906,000
0
909,727
0
910,000
1,551,000
1,552,000
1,555,000
1,556,000
1,558,000
1,559,000
1,560,000
1,546,453
1,536,000
1,516,000
1,510,000
1,506,000
1,496,868
1,495,000
1,490,000
1,485,120
1,484,000
1,483,000
1,484,000
1,483,269
1,485,000
1,486,000
1,487,000
1,490,675
1,494,000
1,496,000
1,497,000
1,497,543
1,503,000
1,505,000
1,506,000
1,504,682
1,476,000
1,440,000
1,423,000
1,415,000
1,416,000
1,416,000
1,416,000
1,416,000
1,417,000
1,417,000
1,417,000
1,418,000
1,416,000
1,400,000
1,392,000
1,387,000
1,390,000
1,367,000
1,361,000
1,349,000
1,352,000
1,353,000
1,341,000
1,336,000
1,337,000
1,338,000
1,338,000
1,339,000
1,339,000
1,339,000
1,340,000
1,340,000
1,340,000
1,341,000
1,341,000
1,342,000
1,343,000
1,343,000
1,343,000
1,343,000
1,343,000
1,343,000
1,344,000
1,345,000
1,345,000
1,345,000
1,345,000
1,346,000
1,346,000
1,346,000
1,346,000
1,346,000
1,346,000
1,347,000
1,347,000
1,347,000
1,347,000
1,347,000
1,347,000
1,347,000
1,348,000
1,348,000
1,348,000
1,348,000
1,348,0001,348,0001,348,0001,348,0001,347,0001,347,0001,347,0001,347,0001,347,0001,347,0001,347,0001,346,0001,346,0001,346,0001,346,0001,346,0001,346,0001,345,0001,345,0001,345,0001,345,0001,344,0001,343,0001,343,0001,343,0001,343,0001,343,0001,343,0001,342,0001,341,0001,341,0001,340,0001,340,0001,340,0001,339,0001,339,0001,339,0001,338,0001,338,0001,337,0001,336,0001,341,0001,353,0001,352,0001,349,0001,361,0001,367,0001,390,0001,387,0001,392,0001,400,0001,416,0001,418,0001,417,0001,417,0001,417,0001,416,0001,416,0001,416,0001,416,0001,415,0001,423,0001,440,0001,476,0001,504,6821,506,0001,505,0001,503,0001,497,5431,497,0001,496,0001,494,0001,490,6751,487,0001,486,0001,485,0001,483,2691,484,0001,483,0001,484,0001,485,1201,490,0001,495,0001,496,8681,506,0001,510,0001,516,0001,536,0001,546,4531,560,0001,559,0001,558,0001,556,0001,555,0001,552,0001,551,000910,0000909,7270906,000000894,000000886,00000000000762,000000758,000000753,000000750,000000747,000000372,000000370,000000370,000000370,000000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,858,000
0
0
0
-1,969,000
0
0
0
-2,207,000
0
0
0
-2,511,000
0
0
0
-4,913,000
0
0
0
-5,402,606
0
0
0
-5,734,000
-5,836,523
0
0
-5,955,040
0
0
0
-6,395,002
0
0
0
-6,536,307
0
0
0
-6,510,790
0
0
0
-7,273,302
0
0
0
-9,309,000
0
0
0
-9,383,000
0
0
0
-9,850,000
0
0
0
-10,084,000
0
0
0
-9,966,000
0
0
0
-9,981,000
0
0
0
-10,303,000
0
0
0
-11,082,000
0
0
0
-11,356,000
0
0
0
-10,859,000
0
0
0
-11,430,000
0
0
0
-11,251,000
0
0
0
0
0
0
0
0
0
0
1,773,000
-48,000
1,368,000
1,475,000
1,318,000
1,597,000
1,597,0001,318,0001,475,0001,368,000-48,0001,773,0000000000000-11,251,000000-11,430,000000-10,859,000000-11,356,000000-11,082,000000-10,303,000000-9,981,000000-9,966,000000-10,084,000000-9,850,000000-9,383,000000-9,309,000000-7,273,302000-6,510,790000-6,536,307000-6,395,002000-5,955,04000-5,836,523-5,734,000000-5,402,606000-4,913,000000-2,511,000000-2,207,000000-1,969,000000-1,858,00000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,448,951
3,151,000
3,157,000
3,165,000
3,174,000
3,275,000
3,278,000
3,280,000
3,281,000
3,296,000
3,299,000
3,300,000
3,301,000
3,436,000
3,439,000
3,440,000
3,440,000
3,449,000
3,450,000
3,450,000
0
03,450,0003,450,0003,449,0003,440,0003,440,0003,439,0003,436,0003,301,0003,300,0003,299,0003,296,0003,281,0003,280,0003,278,0003,275,0003,174,0003,165,0003,157,0003,151,00010,448,951000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000-1,000,000,000,000,000-11,878,957,527,707-12,041,154-8,387,980-8,797,073-8,579,299-8,334,598-8,311,435-9,040,220-9,216,432-10,036,500-10,310,403-10,629,571-11,115,844-10,495,980-11,010,530-11,778,964-12,695,331-12,026,011-11,906,762-11,605,197-11,106,342-10,691,314-11,368,764-11,408,550-10,534,718-11,696,225-11,113,616-11,688,315-11,797,999-12,119,450-10,976,035-11,302,724-10,823,123-11,069,075-12,002,381-12,099,024-12,462,390-10,908,040-11,301,9490-30,981,698-15,735,088-16,469,690-14,741,247-12,318,682-11,165,332-10,078,956-8,830,209-8,250,685-7,414,636-7,067,706-6,823,578-6,544,450-6,584,357-6,462,668-5,767,092-5,358,046-5,109,6800000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
720,000
0
0
0
1,080,000
0
0
0
1,414,000
0
0
0
1,919,000
0
0
0
1,985,000
0
0
0
2,458,000
0
0
0
2,819,000
0
0
0
3,788,000
0
0
0
4,264,000
0
0
0
-3,687,640
0
0
0
0
339,000
0
0
0
949,000
0
1,852,237
0
1,796,000
0
1,848,364
0
2,232,000
4,517,000
4,813,000
5,333,000
1,879,000
1,922,000
1,966,000
1,992,000
2,039,914
2,061,000
2,099,000
2,117,000
2,129,000
2,137,301
2,158,000
-590,000
2,186,240
-466,000
-442,000
-414,000
-339,405
-164,000
-115,000
-28,000
240,600
465,000
611,000
725,000
922,311
1,230,000
1,471,000
1,555,000
1,626,206
1,723,000
1,743,000
1,964,000
1,894,000
2,027,000
2,044,000
2,163,000
2,268,000
2,431,000
2,438,000
2,553,000
2,690,000
2,670,000
2,776,000
2,904,000
3,275,000
3,430,000
3,634,000
3,795,000
3,809,000
4,046,000
4,645,000
4,762,000
4,748,000
4,801,000
4,938,000
4,895,000
4,998,000
4,988,000
4,925,000
4,768,000
5,171,000
5,168,000
5,314,000
5,347,000
5,174,000
5,277,000
5,322,000
5,300,000
5,066,000
4,941,000
5,016,000
5,213,000
5,152,000
5,107,000
5,073,000
5,162,000
5,529,000
5,395,000
5,625,000
5,885,000
6,486,000
6,819,000
6,651,000
6,296,000
5,764,000
5,197,000
5,203,000
3,440,000
4,888,000
3,449,000
3,450,000
3,450,000
3,163,000
3,163,0003,450,0003,450,0003,449,0004,888,0003,440,0005,203,0005,197,0005,764,0006,296,0006,651,0006,819,0006,486,0005,885,0005,625,0005,395,0005,529,0005,162,0005,073,0005,107,0005,152,0005,213,0005,016,0004,941,0005,066,0005,300,0005,322,0005,277,0005,174,0005,347,0005,314,0005,168,0005,171,0004,768,0004,925,0004,988,0004,998,0004,895,0004,938,0004,801,0004,748,0004,762,0004,645,0004,046,0003,809,0003,795,0003,634,0003,430,0003,275,0002,904,0002,776,0002,670,0002,690,0002,553,0002,438,0002,431,0002,268,0002,163,0002,044,0002,027,0001,894,0001,964,0001,743,0001,723,0001,626,2061,555,0001,471,0001,230,000922,311725,000611,000465,000240,600-28,000-115,000-164,000-339,405-414,000-442,000-466,0002,186,240-590,0002,158,0002,137,3012,129,0002,117,0002,099,0002,061,0002,039,9141,992,0001,966,0001,922,0001,879,0005,333,0004,813,0004,517,0002,232,00001,848,36401,796,00001,852,2370949,000000339,0000000-3,687,6400004,264,0000003,788,0000002,819,0000002,458,0000001,985,0000001,919,0000001,414,0000001,080,000000720,000000



Balance Sheet

Currency in GBP. All numbers in thousands.




Cash Flow

Currency in GBP. All numbers in thousands.




Income Statement

Currency in GBP. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue30,328,000
Cost of Revenue-9,076,000
Gross Profit21,252,00021,252,000
 
Operating Income (+$)
Gross Profit21,252,000
Operating Expense-14,259,000
Operating Income6,993,0006,993,000
 
Operating Expense (+$)
Research Development5,245,000
Selling General Administrative9,385,000
Selling And Marketing Expenses371,000
Operating Expense14,259,00015,001,000
 
Net Interest Income (+$)
Interest Income48,000
Interest Expense-775,000
Other Finance Cost-8,000
Net Interest Income-735,000
 
Pretax Income (+$)
Operating Income6,993,000
Net Interest Income-735,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)6,069,0007,917,000
EBIT - interestExpense = 6,218,000
5,684,000
5,703,000
Interest Expense775,000
Earnings Before Interest and Taxes (EBIT)6,993,0006,844,000
Earnings Before Interest and Taxes (EBITDA)9,287,000
 
After tax Income (+$)
Income Before Tax6,069,000
Tax Provision-756,000
Net Income From Continuing Ops6,535,0005,313,000
Net Income4,928,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses23,335,000
Total Other Income/Expenses Net-924,000735,000
 

Technical Analysis of GlaxoSmithKline PLC ADR
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of GlaxoSmithKline PLC ADR. The general trend of GlaxoSmithKline PLC ADR is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine GlaxoSmithKline PLC ADR's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of GlaxoSmithKline PLC ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 43.84 < 44.25.

The bearish price targets are: 41.78 > 41.75 > 40.76.

Tweet this
GlaxoSmithKline PLC ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of GlaxoSmithKline PLC ADR. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

GlaxoSmithKline PLC ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of GlaxoSmithKline PLC ADR. The current macd is 0.28946023.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the GlaxoSmithKline PLC ADR price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for GlaxoSmithKline PLC ADR. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the GlaxoSmithKline PLC ADR price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
GlaxoSmithKline PLC ADR Daily Moving Average Convergence/Divergence (MACD) ChartGlaxoSmithKline PLC ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of GlaxoSmithKline PLC ADR. The current adx is 22.52.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy GlaxoSmithKline PLC ADR shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
GlaxoSmithKline PLC ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of GlaxoSmithKline PLC ADR. The current sar is 43.45.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
GlaxoSmithKline PLC ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of GlaxoSmithKline PLC ADR. The current rsi is 59.64. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
GlaxoSmithKline PLC ADR Daily Relative Strength Index (RSI) ChartGlaxoSmithKline PLC ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of GlaxoSmithKline PLC ADR. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the GlaxoSmithKline PLC ADR price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
GlaxoSmithKline PLC ADR Daily Stochastic Oscillator ChartGlaxoSmithKline PLC ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of GlaxoSmithKline PLC ADR. The current cci is 37.25.

GlaxoSmithKline PLC ADR Daily Commodity Channel Index (CCI) ChartGlaxoSmithKline PLC ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of GlaxoSmithKline PLC ADR. The current cmo is 20.19.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
GlaxoSmithKline PLC ADR Daily Chande Momentum Oscillator (CMO) ChartGlaxoSmithKline PLC ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of GlaxoSmithKline PLC ADR. The current willr is -27.05882353.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that GlaxoSmithKline PLC ADR is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
GlaxoSmithKline PLC ADR Daily Williams %R ChartGlaxoSmithKline PLC ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of GlaxoSmithKline PLC ADR.

GlaxoSmithKline PLC ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of GlaxoSmithKline PLC ADR. The current atr is 0.54972029.

GlaxoSmithKline PLC ADR Daily Average True Range (ATR) ChartGlaxoSmithKline PLC ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of GlaxoSmithKline PLC ADR. The current obv is -41,134,448.

GlaxoSmithKline PLC ADR Daily On-Balance Volume (OBV) ChartGlaxoSmithKline PLC ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of GlaxoSmithKline PLC ADR. The current mfi is 49.45.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
GlaxoSmithKline PLC ADR Daily Money Flow Index (MFI) ChartGlaxoSmithKline PLC ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for GlaxoSmithKline PLC ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

GlaxoSmithKline PLC ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of GlaxoSmithKline PLC ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.638
Ma 20Greater thanMa 5042.643
Ma 50Greater thanMa 10041.580
Ma 100Greater thanMa 20038.970
OpenGreater thanClose42.580
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of GlaxoSmithKline PLC ADR with someone you think should read this too:
  • Are you bullish or bearish on GlaxoSmithKline PLC ADR? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about GlaxoSmithKline PLC ADR? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about GlaxoSmithKline PLC ADR

I send you an email if I find something interesting about GlaxoSmithKline PLC ADR.


Comments

How you think about this?

Leave a comment

Stay informed about GlaxoSmithKline PLC ADR.

Receive notifications about GlaxoSmithKline PLC ADR in your mailbox!